Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 3
2000 2
2001 4
2002 2
2003 5
2004 2
2005 2
2006 1
2008 2
2010 1
2011 1
2012 3
2013 2
2014 2
2015 3
2016 2
2017 1
2018 1
2019 1
2020 3
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis of mast cell activation syndrome: a global "consensus-2".
Afrin LB, Ackerley MB, Bluestein LS, Brewer JH, Brook JB, Buchanan AD, Cuni JR, Davey WP, Dempsey TT, Dorff SR, Dubravec MS, Guggenheim AG, Hindman KJ, Hoffman B, Kaufman DL, Kratzer SJ, Lee TM, Marantz MS, Maxwell AJ, McCann KK, McKee DL, Menk Otto L, Pace LA, Perkins DD, Radovsky L, Raleigh MS, Rapaport SA, Reinhold EJ, Renneker ML, Robinson WA, Roland AM, Rosenbloom ES, Rowe PC, Ruhoy IS, Saperstein DS, Schlosser DA, Schofield JR, Settle JE, Weinstock LB, Wengenroth M, Westaway M, Xi SC, Molderings GJ. Afrin LB, et al. Among authors: saperstein ds. Diagnosis (Berl). 2020 Apr 22;8(2):137-152. doi: 10.1515/dx-2020-0005. Print 2021 May 26. Diagnosis (Berl). 2020. PMID: 32324159 Free article. Review.
Progressive Muscular Atrophy.
Liewluck T, Saperstein DS. Liewluck T, et al. Among authors: saperstein ds. Neurol Clin. 2015 Nov;33(4):761-73. doi: 10.1016/j.ncl.2015.07.005. Neurol Clin. 2015. PMID: 26515620 Review.
Small Fiber Neuropathy.
Saperstein DS. Saperstein DS. Neurol Clin. 2020 Aug;38(3):607-618. doi: 10.1016/j.ncl.2020.04.001. Neurol Clin. 2020. PMID: 32703472 Review.
Muscle channelopathies.
Saperstein DS. Saperstein DS. Semin Neurol. 2008 Apr;28(2):260-9. doi: 10.1055/s-2008-1062262. Semin Neurol. 2008. PMID: 18351527 Review.
Laboratory evaluation of peripheral neuropathy.
Levine TD, Saperstein DS. Levine TD, et al. Among authors: saperstein ds. Neurol Clin. 2013 May;31(2):363-76. doi: 10.1016/j.ncl.2013.01.004. Epub 2013 Mar 6. Neurol Clin. 2013. PMID: 23642714 Review.
Management of myasthenia gravis.
Saperstein DS, Barohn RJ. Saperstein DS, et al. Semin Neurol. 2004 Mar;24(1):41-8. doi: 10.1055/s-2004-829586. Semin Neurol. 2004. PMID: 15229791 Review.
Acquired immune demyelinating neuropathies.
Dimachkie MM, Saperstein DS. Dimachkie MM, et al. Among authors: saperstein ds. Continuum (Minneap Minn). 2014 Oct;20(5 Peripheral Nervous System Disorders):1241-60. doi: 10.1212/01.CON.0000455883.91426.12. Continuum (Minneap Minn). 2014. PMID: 25299280 Review.
Review process for IVIg treatment: Lessons learned from INSIGHTS neuropathy study.
Levine TD, Katz JS, Barohn R, Vaughan LJ, Dimachkie MM, Saperstein DS, Mozaffar T, Wolfe GI, Mayo MS, Badger GJ, Katzin L, Ritt E, Greer M, DiStefano J, Schmidt PM. Levine TD, et al. Among authors: saperstein ds. Neurol Clin Pract. 2018 Oct;8(5):429-436. doi: 10.1212/CPJ.0000000000000520. Neurol Clin Pract. 2018. PMID: 30564497 Free PMC article. Review.
Phase 2 trial in acetylcholine receptor antibody-positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg study.
Pasnoor M, Bril V, Levine T, Trivedi J, Silvestri NJ, Phadnis M, Katzberg HD, Saperstein DS, Wolfe GI, Herbelin L, Higgs K, Heim AJ, Statland JM, Barohn RJ, Dimachkie MM. Pasnoor M, et al. Among authors: saperstein ds. Eur J Neurol. 2023 May;30(5):1417-1424. doi: 10.1111/ene.15745. Epub 2023 Mar 6. Eur J Neurol. 2023. PMID: 36779862 Clinical Trial.
39 results